Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Coenzyme Q10 Supplementation in the Treatment of Heart Disease

Author(s):  Bramwell Bethany L

Issue:  Mar/Apr 2010 - Compounding for Men
View All Articles in Issue

Page(s):  108-111

Coenzyme Q10 Supplementation in the Treatment of Heart Disease Page 1
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Page 2
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Page 3
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Page 4

Download in electronic PDF format for $75

Abstract:  Significant deficiencies in coenzyme Q10 have been documented in a wide variety of diseases in both animal and human studies. Known predominately for its functions as an antioxidant and membrane stabilizer, coenzyme Q10 supplementation also has been demonstrated to effectively lower blood pressure, decrease total cholesterol and low-density lipoprotein cholesterol, increase levels of high-density lipoprotein cholesterol, and decrease symptoms of dyspnea, peripheral edema, enlarged liver, and insomnia. The majority of clinical work with coenzyme Q10 in the past two decades has focused on its role in heart disease. While usually found in high concentrations in heart muscle cells, both serum and tissue levels of coenzyme Q10 are often lower in people with congestive heart failure. The severity of coenzyme Q10 deficiency is directly related to the severity of heart failure. Correcting deficits in coenzyme Q10 in heart failure patients can mitigate or reverse myocardial dysfunction and necrosis. The addition of co

Related Keywords: heart disease, cardiovascular disease, coenzyme Q10, nutritional supplement, dietary supplementation, high blood pressure, hypertension, cholesterol, low-density lipoprotein, LDL, antioxidant, congestive heart failure, oxidative stress, statins, myocardial infarction, transdermal application, formulation

Related Categories: FORMULATIONS, NUTRITION AND NUTRICEUTICALS, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 448

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A
, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119

Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D
, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2011
Pg. 290-300

Natural Testosterone: Hormone of the Heart
Wright Jonathan V
, Lenard Lane
Mar/Apr 1999
Pg. 88-98

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

Coenzyme Q10: It's Everywhere
Hudson Sonora
Jan/Feb 1999
Pg. 30-33

Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche
Roentsch George
Jan/Feb 1999
Pg. 32

Coenzyme Q10 200-mg Chewable Troches
Allen Loyd V Jr
Mar/Apr 2000
Pg. 129

Coenzyme Q10 100-mg-in-Oil Capsules
Glasnapp Andrew
Jul/Aug 2003
Pg. 291

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
Mar/Apr 2001
Pg. 92-94

Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
Sep/Oct 2001
Pg. 362-364

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
May/Jun 2004
Pg. 169-172

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
Jul/Aug 2004
Pg. 277-283

Return to Top